Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the nuclear medicine diagnostics market grown in recent years?

The market size for nuclear medicine diagnostics has seen rapid growth in the recent past. Its progression from $7.16 billion in 2024 to an estimated $7.94 billion in 2025, displaying a Compound Annual Growth Rate (CAGR) of 11.0%, demonstrates this growth. Factors such as advancements in medical imaging, a higher incidence of chronic diseases, an aging population, applications in oncology, and improved diagnostic accuracy and precision have all contributed to this growth in the historic period.

How is the nuclear medicine diagnostics market size expected to evolve during the forecast period?

Get your nuclear medicine diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report

Which key drivers are propelling the nuclear medicine diagnostics market’s growth?

The growth of the nuclear medicine diagnostics market is set to be driven by the rising demand for nuclear medicine diagnostics. Utilizing radioactive substances within the body, nuclear medicine diagnoses diseases or has the capability to target and remove affected organs and tissue. Primarily, the diagnostic applications of nuclear medicine are used in radiation and other serious treatments. The appealing benefits of accurate results and improved treatment decision-making processes are driving increased demand for nuclear medicine diagnostics. For example, a World Nuclear Association report released in April 2022 estimated that the annual number of nuclear medicine procedures exceeds 40 million, with the demand for radioisotopes growing by as much as 5% annually. Moreover, of the procedures involving radioisotopes in medicine, 90% are performed in over 10,000 hospitals around the globe. Thus, as the demand for nuclear medicine diagnostics grows, so too is the nuclear medicine diagnostics market projected to expand.

What are the market segments in the nuclear medicine diagnostics industry?

The nuclear medicine diagnostics market covered in this report is segmented –

1) By Type: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

2) By Application: Cardiology, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Diagnostic Centers, Research Institutes

Subsegments:

1) By SPECT Radiopharmaceuticals: Technetium-99m-Based Radiopharmaceuticals, Iodine-123-Based Radiopharmaceuticals, Thallium-201-Based Radiopharmaceuticals, Other SPECT Radiopharmaceuticals

2) By PET Radiopharmaceuticals: Fluorine-18-Based Radiopharmaceuticals, Carbon-11-Based Radiopharmaceuticals, Gallium-68-Based Radiopharmaceuticals, Other PET Radiopharmaceuticals

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9415&type=smp

Which leading companies are shaping the growth of the nuclear medicine diagnostics market?

Major companies operating in the nuclear medicine diagnostics market include Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., Eczacibasi-Monrol Nuclear Products Co.

What key trends are currently impacting the nuclear medicine diagnostics market’s development?

The nuclear medicine diagnostics market is predominantly operated by significant corporations such as Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., and Mallinckrodt Pharmaceuticals. Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, and Curium SAS are among others. Cardinal Health Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, and Telix Pharmaceuticals Limited also have a strong presence in the market. With others like Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., and PharmaLogic Holdings Corp dominating the landscape. Lastly, the market also involves an array of companies such as Institute of Isotopes Co Ltd., Global Medical Solutions LLC, Theragnostics Ltd., and Eczacıbaşı-Monrol Nuclear Products Co.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9415

Which geographic areas are influencing the growth of the nuclear medicine diagnostics market?

North America was the largest region in the nuclear medicine diagnostics market in 2024. The regions covered in the nuclear medicine diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: